US EditionBlood Community Comment Letter on FDA Guidance for HCT/P Safety
Summary by America's Blood Centers
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Blood Community Comment Letter on FDA Guidance for HCT/P Safety
America’s Blood Centers (ABC), the Association for the Advancement of Blood and Biotherapies (AABB), and the American Red Cross (ARC) submitted this joint comment letter to the FDA, offering critical feedback on recent guidance for human cells, tissues, and cellular and tissue-based products (HCT/Ps). The blood community is requesting a clear direction on prioritizing the myriad of potential sepsis-causing pathogens for screening, emphasizing th…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
